Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study

Table 4

Risk factors associated with COVID-19 patients with diabetes.

	Univariable OR (95% CI)	value	Multivariable OR (95% CI)	value
Demographics and clinical characteristics
Age	1.05 (1.03, 1.07)	<.0001	1.04 (1.00, 1.13)	0.4201
Sex	0.50 (0.27, 0.94)	0.0315	4.04 (0.34, 48.40)	0.271
Laboratory findings
Triglyceride, mmol/L
<0.24
0.24-1.86	9.84 (1.89, 51.34)	0.0067
>1.86	0.98 (0.64, 1.49)	0.9187
Prothrombin time, s
<9.5
9.5-14.5	0.72 (0.53, 0.98)	0.0339	0.60 (0.27, 1.33)	0.2084
>14.5	0.68 (0.17 2.84)	0.5997
Cystatin C, mg/L	4.01 (1.17, 13.71)	0.0271
Uric acid, umol/L
<140	0.98 (0.95, 1.02)	0.3509
140-440	1.00 (1.00, 1.01)	0.7094
>440	1.02 (1.00, 1.03)	0.0473
α-Hydroxybutyrate dehydrogenase, IU/L
<72
72-182	0.98 (0.95, 1.00)	0.0797
>182	1.01 (1.00, 1.02)	0.0419
Anion gap, mmol/L	1.47 (1.14, 1.90)	0.0033
Total cholesterol, mmol/L
<2.8	0.81 (0.03, 24.33)	0.9037
2.8-6	1.83 (1.10, 3.05)	0.0077	1.31 (0.35, 4.95)	0.69
>6	0.95 (0.62, 1.45)	0.8054
Glucose, mmol/L	7.33 (1.66, 32.31)	0.0085	14.85 (0.74, 299.81)	0.0785

OR: odds ratio.